News
Eli Lilly’s Cyramza becomes first FDA-approved gastric cancer drug
Eli Lilly has obtained US Food and Drug Administration approval for its Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine or...
News
Abbvie starts Phase III trial of lung cancer drug veliparib
US-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose) polymerase (PARP) inhibitor 'veliparib (ABT-888)' in patients with previously untreated locally advanced or metastatic squamous non-small cell lung cancer...
News
Roche Signs Licensing Agreement with Sysmex Inostics GmbH for emPCR Patent Portfolio
Pleasanton, CA, USA, 21 February 2014 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a licensing agreement with Sysmex Inostics GmbH for its emPCR portfolio of patents. Under the terms of the licensing agreement, Roche grants Sysmex Inostics...
News
Nuevolution Announces License Agreement with Merck
Copenhagen, Denmark, February 21, 2014 - Today announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the United States and Canada, for small molecule compounds targeting an...
News
Ferrer to develop Lorediplon for insomnia with Ildong Pharmaceuticals and Ergomed Clinical Research
A Phase IIa clinical study will test the efficacy, safety and tolerability profile Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has executed two agreements; with Ildong Pharmaceuticals Co Ltd, Korea and...
News
Health ministry turns down SLAs’ demand for amending D&C Rules to define role of SLAs in monitoring clinical trials
3rd February 2014, India - The Union health ministry of India has turned down some of the state drug controllers' demand for an amendment in Rule 122DAC of the Drugs & Cosmetics Act to further define the role of...
News
Cancer Aid Society urges govt to relax norms on oral morphine to provide relief to cancer patients
The Cancer Aid Society of India has urged the government to relax norms with respect to availability and accessibility of oral morphine in the country as thousands of cancer patients are enduring immense pain due to non availability of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read